Rivfloza Disease Interactions
There are 2 disease interactions with Rivfloza (nedosiran).
Nedosiran (applies to Rivfloza) hepatic dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Nedosiran has not been studied in patients with moderate or severe liver disease (total bilirubin greater than 1.5 upper limit of normal with any aspartate aminotransferase).
Nedosiran (applies to Rivfloza) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Nedosiran has not been studied in patients with severe renal dysfunction (eGFR less than 30 mL/min/1.73m2).
Switch to professional interaction data
Report options
More about Rivfloza (nedosiran)
- Rivfloza consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Aqneursa
Aqneursa information from Drugs.com, includes Aqneursa side effects, interactions and indications.
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
